A5060964356- Renal cell carcinoma treatment
- Bladder and Urothelial Cancer Treatments
- Inflammatory Biomarkers in Disease Prognosis
- Renal and related cancers
- Nanoplatforms for cancer theranostics
- Immunotherapy and Immune Responses
- Pancreatic and Hepatic Oncology Research
- Cancer, Lipids, and Metabolism
Nanjing Drum Tower Hospital
2018-2019
The preoperative neutrophil-to-lymphocyte ratio (NLR), C-reactive protein/albumin (CRP/Alb ratio) and platelet-to-lymphocyte (PLR) have been demonstrated to predict the clinical outcome of various human cancer, including renal cell carcinoma(RCC). aim our study was explore prognostic values these ratios in patients with Xp11.2 translocation/TFE3 gene fusions carcinoma (Xp11.2 tRCC). A retrospective multicentre performed 82 tRCC who underwent radical or partial nephrectomy. optimal cutoff...
The Fuhrman and World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading systems are widely used to predict survival for patients with conventional renal cell carcinoma. To determine the validity nuclear (both WHO/ISUP) individual components system in predicting prognosis Xp11.2 translocation carcinoma (Xp11.2 tRCC), we identified followed up 47 tRCC our center from January 2007 June 2017. WHO/ISUP was reassigned by two pathologists. Nuclear size shape were...
Aim: To evaluate the prognostic values of some preoperative inflammation-based factors including C-reactive protein/albumin ratio (CRP/Alb) and platelet level in papillary renal cell carcinoma (PRCC). Materials & methods: A total 108 PRCC patients underwent partial or radical nephrectomy were retrospectively analyzed. The determined with Kaplan–Meier analysis, univariate multivariate COX regression models. Results: CRP/Alb both significantly associated subtype, Fuhrman grade, tumor stage,...
The aim of the present study was to investigate incidence and significance psammoma bodies (PBs) in Xp11.2 translocation renal cell carcinoma (Xp11.2 tRCC) papillary (PRCC). presence PBs, irregular calcifications, hyaline globules nested architecture RCC tissues, which included 47 cases tRCC 95 PRCC, examined by two pathologists. Compared with patients exhibited a higher frequency architecture. PBs combination occurrence achieved specificity 93.7% when diagnosing tRCC. However, there were no...